Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “New York”
Sponsor: Eli Lilly and Company
Breast Neoplasms · Colorectal Neoplasms · Prostate Neoplasm · Endometrial Neoplasms
United States, Canada, China, France, Germany +2 more
Sponsor: Celgene
Neoplasms
United States, Australia, Austria, Belgium, Canada +16 more
- A Study to Evaluate the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC)Active Not Recruiting
Sponsor: Hoffmann-La Roche
Non-Small Cell Lung Cancer
United States, Argentina, Australia, Belgium, Brazil +22 more
Sponsor: Boehringer Ingelheim
Systemic Sclerosis
United States, Argentina, Australia, Austria, Belgium +40 more
Sponsor: InduPro, Inc.
Advanced Solid Tumor · Metastatic Solid Tumor · Head and Neck Squamous Cell Carcinoma · Cutaneous Squamous Cell Carcinoma
United States
Sponsor: National Cancer Institute (NCI)
Lung Non-Small Cell Carcinoma
United States
Sponsor: Boehringer Ingelheim
Diabetes Mellitus, Type 2 · Hypertension · Cardiovascular Diseases
United States, Argentina, Australia, Austria, Belgium +46 more
Sponsor: Hoffmann-La Roche
Lymphoma
United States, Australia, Brazil, Canada, China +8 more
Sponsor: Johns Hopkins University
Hiv
United States
- Evaluation of the Long-term Safety and Effectiveness of Suzetrigine (SUZ) in Participants With Painful Diabetic Peripheral Neuropathy (DPN)Active Not Recruiting
Sponsor: Vertex Pharmaceuticals Incorporated
Diabetic Peripheral Neuropathic Pain
United States
- Study on an Investigational Yellow Fever Vaccine Compared With YF-VAX in Adults in the USAActive Not Recruiting
Sponsor: Sanofi Pasteur, a Sanofi Company
Yellow Fever · Healthy Volunteers
United States
- FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease ProgressionNot Yet Recruiting
Sponsor: Boehringer Ingelheim
Interstitial Lung Diseases
United States, Argentina, Austria, Belgium, Brazil +14 more
Sponsor: Sellas Life Sciences Group
Hematologic Malignancies
United States, China
Sponsor: Hoffmann-La Roche
Lupus Nephritis
United States, Brazil, Canada, France, Italy +7 more
- COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DMEActive Not Recruiting
Sponsor: EyePoint Pharmaceuticals, Inc.
Diabetic Macular Edema · DME · Diabetic Macular Edema (DME)
United States, Germany, Israel, Poland, Slovakia
Sponsor: Amgen
Atherosclerotic Cardiovascular Disease · Overweight · Obesity
United States, Argentina, Australia, Austria, Belgium +31 more
Sponsor: Merck Sharp & Dohme LLC
DLBCL · Diffuse Large B-Cell Lymphoma
United States, Argentina, Australia, Brazil, Canada +21 more
Sponsor: Boston Scientific Corporation
Heart Failure
United States
Sponsor: Boston Scientific Corporation
Chronic Low-back Pain · Vertebrogenic Pain Syndrome
United States
Sponsor: Merck Sharp & Dohme LLC
B-cell Acute Lymphoblastic Leukemia · Diffuse Large B-cell Lymphoma · Burkitt Lymphoma · Neuroblastoma
United States, Australia, Belgium, Brazil, Canada +18 more
Sponsor: Hoffmann-La Roche
Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer
United States, Argentina, Australia, Austria, Belgium +32 more
Sponsor: Hoffmann-La Roche
HER2-positive Breast Cancer
United States, Argentina, Australia, Austria, Belgium +20 more
Sponsor: Ionis Pharmaceuticals, Inc.
Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)
United States, Argentina, Australia, Austria, Belgium +16 more
- Dose Escalation and Expansion Study of FLX475 Monotherapy and in Combination With PembrolizumabCompleted
Sponsor: RAPT Therapeutics, Inc.
Advanced Cancer
United States, Australia, Hong Kong, South Korea, Taiwan +1 more
Sponsor: Eli Lilly and Company
Type 2 Diabetes
United States, China, India, Japan, Mexico +1 more